NASDAQ: CURX
Curanex Pharmaceuticals Inc Stock Ownership - Who owns Curanex Pharmaceuticals?

Insider buying vs selling

Have Curanex Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CURX insiders and whales buy or sell their stock.

CURX Shareholders

What type of owners hold Curanex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Chang Liu3.82%1,082,200$386.35kInsider
Jun Liu2.43%690,000$246.33kInsider
Dian Ying Jing2.43%690,000$246.33kInsider
Ubs Group Ag0.23%64,516$23.03kInstitution
Citadel Advisors LLC0.23%64,067$22.87kInstitution
Jane Street Group LLC0.12%35,277$12.59kInstitution
Two Sigma Securities LLC0.11%32,435$11.58kInstitution
Jump Financial LLC0.10%27,200$9.71kInstitution
Millennium Management LLC0.07%19,154$6.84kInstitution
Geode Capital Management LLC0.07%18,670$6.67kInstitution

1 of 2

CURX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CURX1.01%8.69%
ICU7.54%92.46%Net BuyingNet Buying
INAB4.74%95.26%Net BuyingNet Buying
ERNA0.38%99.62%Net Buying
BRTX0.37%99.63%Net Buying

Curanex Pharmaceuticals Stock Ownership FAQ

Who owns Curanex Pharmaceuticals?

Curanex Pharmaceuticals (NASDAQ: CURX) is owned by 1.01% institutional shareholders, 8.69% Curanex Pharmaceuticals insiders, and 90.30% retail investors. Chang Liu is the largest individual Curanex Pharmaceuticals shareholder, owning 1.08M shares representing 3.82% of the company. Chang Liu's Curanex Pharmaceuticals shares are currently valued at $387.43k.

If you're new to stock investing, here's how to buy Curanex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.